Latest filing published 30 Mar 2017 for Aveo Pharmaceuticals, INC., €32k.
Insider track record
No signal scores available.
Keith S. Ehrlich: trading record in brief
Keith S. Ehrlich discloses dealings in 2 companies, chiefly Madrigal Pharmaceuticals, Inc. and Aveo Pharmaceuticals, Inc. In total, 7 filings cover trades dated from 5 January 2009 to 28 March 2017.
The open-market record consists of 3 sales worth €51k, with no purchase. Besides market trades, the filings include 3 share grants.
The newest entry dates from 30 March 2017: a transaction of €32k, in Aveo Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Keith S. Ehrlich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 70,000 shares@ US$0.50100.0% of flowCommon StockSEC:0000899243-17-008968:0
- 51,813 sharesCommon StockSEC:0000899243-16-020201:0
- 4,397 shares@ US$4.70Common StockSEC:0001179110-12-004228:0
- 2,537 shares@ US$5.51Common StockSEC:0001179110-11-004056:0
- 4,397 shares0Common StockSEC:0001179110-11-004056:1
- 5,284 shares0Common StockSEC:0001179110-10-004352:0
- 5,600 shares@ US$6.18Common StockSEC:0001179110-09-000608:0
7 of 7 declarations
